Powered by

Home Hindi

Covid Vaccine Moderna price to be $50-$60

Moderna is planning to price its covid vaccine at $50-$60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech.

By Shrey Srivastava
New Update
Covid Vaccine Moderna price to be $50-$60

On Tuesday, the Financial Express reported that Moderna Inc is planning to price its covid vaccine at $50-$60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, citing sources familiar with the matter. The price of the vaccine would apply to the USA and other high-income countries, according to the report.

ALSO READ: Oxford's 'Covidshield' vaccine production in India begins

Corona Vaccine Deal

In a $2 billion deal with the US Government by the Pfizer Inc and its German partner BioNTeck the price of the vaccine is higher than the usual that is; from $39 for a course, or $19.50 per dose to $50-$60 for a course, or $25-$35 per dose (pre-proposed price by the company).

A Moderna spokesperson said the company was in discussions with governments about potential supply of the coronavirus vaccine, called mRNA-1273, but did not share any details on pricing “given the confidential nature of the discussions and contracts.”

The final price for Moderna’s COVID vaccine has yet to be determined, a person familiar with the matter told Reuters. Pfizer, Moderna and Merck & Co are planning to sell their vaccines at a profit, while some other drugmakers, including Johnson & Johnson, have announced their plans to price coronavirus vaccines on a not-for-profit basis.

ALSO READ: Corona Vaccine: जल्द आएगा कोरोना का टीका, मानव परीक्षण सफल रहा तो बनेंगे 1 अरब से ज्यादा वैक्सीन!

COVID-19 cases

It's been around 6 months since coronavirus attacked the whole world which made everybody in the world stay where they were. The current count of coronavirus cases in the world is 16,917,714 (credit-worldometer) among which the recovered count is 10,482,364 and, those who died due to this highly infected virus are 663,942.The whole world is looking forward for the vaccine of coronavirus to come as early as possible.

Written by Shrey Srivastava, a Journalism graduate from the Indian Institute of Mass Communication, New Delhi. He writes for Politics, Education and International affairs.

You can connect with Ground Report on FacebookTwitter and, Whatsapp, and mail us at [email protected] to send us your suggestions and writeups.